| Product Code: ETC10086141 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Therapeutic Vaccines Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Therapeutic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Therapeutic Vaccines Market - Industry Life Cycle |
3.4 Vietnam Therapeutic Vaccines Market - Porter's Five Forces |
3.5 Vietnam Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Vietnam Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2021 & 2031F |
4 Vietnam Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Vietnam |
4.2.2 Growing government initiatives for vaccination programs |
4.2.3 Rising healthcare expenditure and focus on preventive healthcare |
4.3 Market Restraints |
4.3.1 Limited awareness about therapeutic vaccines among the population |
4.3.2 High cost associated with developing and manufacturing vaccines |
4.3.3 Regulatory challenges and approval processes for vaccines in Vietnam |
5 Vietnam Therapeutic Vaccines Market Trends |
6 Vietnam Therapeutic Vaccines Market, By Types |
6.1 Vietnam Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Therapeutic Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Vietnam Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2021- 2031F |
6.1.4 Vietnam Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2021- 2031F |
6.1.5 Vietnam Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2021- 2031F |
6.2 Vietnam Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2021- 2031F |
6.2.3 Vietnam Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2021- 2031F |
6.2.4 Vietnam Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2021- 2031F |
6.2.5 Vietnam Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F |
6.2.6 Vietnam Therapeutic Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 Vietnam Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 Vietnam Therapeutic Vaccines Market Export to Major Countries |
7.2 Vietnam Therapeutic Vaccines Market Imports from Major Countries |
8 Vietnam Therapeutic Vaccines Market Key Performance Indicators |
8.1 Number of individuals vaccinated with therapeutic vaccines |
8.2 Rate of adoption of new vaccines in the market |
8.3 Investment in research and development for vaccine innovation |
8.4 Percentage of healthcare providers recommending therapeutic vaccines |
8.5 Immunization coverage rate for target diseases in Vietnam |
9 Vietnam Therapeutic Vaccines Market - Opportunity Assessment |
9.1 Vietnam Therapeutic Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Vietnam Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2021 & 2031F |
10 Vietnam Therapeutic Vaccines Market - Competitive Landscape |
10.1 Vietnam Therapeutic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here